Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ESPIN CAPSULE 25 MG - HSA Drug Approval Details

Approvals/HSA/ESPIN CAPSULE 25 MG

Approved

THERAPEUTIC

ESPIN CAPSULE 25 MG

TAEJOON PHARM CO LTD (KOREA, REPUBLIC OF)🇸🇬 Health Sciences Authority

Approval Date: Jan 6, 1999
Approval ID: 39a8e42ef4afe0a3
Company: TAEJOON PHARM CO LTD (KOREA, REPUBLIC OF)
Type: Therapeutic

Approval Details

Approval Id: 39a8e42ef4afe0a3
Drug Name: ESPIN CAPSULE 25 MG
Product Name: ESPIN CAPSULE 25 MG
Approval Number: SIN10607P
Approval Date: 1999-01-06
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Licence Holder: PHARMAFORTE SINGAPORE PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: CAPSULE
Route Of Administration: ORAL
Atc Code: N06AA16
Atc Item Name: dosulepin
Pharma Manufacturer Name: PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path: /organization/pharmaforte-singapore-pte-ltd

Active Ingredients

DOSULEPIN HCl

25 mg

DOSULEPIN HCL

25 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 6, 1999

Approval ID

39a8e42ef4afe0a3

Type

Therapeutic

Back to HSA Approvals